SYNERGY PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
47 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Forbearance Agreements (2)
- Indenture Agreements (1)
- Loan Agreements (3)
- Note Agreements (2)
- Purchase Agreements (12)
- Stock Agreements (4)
- Subscription Agreements (1)
- Term Sheets (1)
- Underwriting Agreements (5)
- Waiver Agreements (5)
- Warrant Agreements (9)
- Amended and Restated Asset Purchase Agreement by and among, Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc. and Bausch Health... (Filed With SEC on January 10, 2019)
- Term Sheet, dated December 11, 2018, by and between Synergy Pharmaceuticals Inc. and CRG Servicing, LLC (Filed With SEC on December 13, 2018)
- Asset Purchase Agreement by and among, Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc. and Bausch Health Ireland Limited, dated... (Filed With SEC on December 13, 2018)
- Amendment to Limited Forbearance Agreement, dated as of December 5, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative... (Filed With SEC on December 6, 2018)
- Limited Forbearance Agreement, dated as of November 21, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (Filed With SEC on November 26, 2018)
- Amendment and Waiver No. 6, dated as of November 16, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (Filed With SEC on November 19, 2018)
- Amendment and Waiver No. 5, dated as of November 13, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (Filed With SEC on November 14, 2018)
- License, Development and Commercialization Agreement dated as of August 3, 2018 by and between Synergy Pharmaceuticals Inc. and Shandong Luoxin Pharmaceutical Group Stock Co., Ltd (Filed With SEC on November 9, 2018)
- Waiver No. 4, dated as of November 6, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and collateral agent and... (Filed With SEC on November 6, 2018)
- Amendment and Waiver No. 3, dated as of October 30, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (Filed With SEC on October 31, 2018)
- Amendment No. 2 to Term Loan Agreement, dated August 28, 2018, among Synergy Pharmaceuticals Inc., the Subsidiary Guarantors as from time to time party hereto, the Lenders listed... (Filed With SEC on August 31, 2018)
- Form of Waiver No 2 dated as of June 12, 2018 (Filed With SEC on June 13, 2018)
- Amendment No. 1 dated as of February 26, 2018 to Term Loan Agreement dated as of September 1, 2017 between Synergy Pharmaceuticals Inc. and CRG Servicing LLC (Filed With SEC on March 1, 2018)
- Form of Warrant Agency Agreement (including the form of Warrant certificate) (Filed With SEC on November 15, 2017)
- Underwriting Agreement by and between Synergy Pharmaceuticals Inc. and Jefferies LLC, as representative of the several underwriters, dated November 13, 2017 (Filed With SEC on November 15, 2017)
- SYNERGY PHARMACEUTICALS INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of February 28, 2017 to Indenture Dated as of November3,... (Filed With SEC on March 1, 2017)
- 20,325,204 Shares SYNERGY PHARMACEUTICALS INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 2, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 5, 2016)
- SYNERGY PHARMACEUTICALS INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 3, 2014 7.50% Convertible Senior Notes due 2019 (Filed With SEC on November 3, 2014)
- 16,375,000 Shares SYNERGY PHARMACEUTICALS INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 11, 2013)
- ASSET PURCHASE AGREEMENT between BRISTOL-MYERS SQUIBB COMPANY, and SYNERGY PHARMACEUTICALS, INC. Dated as of August 17, 2012 (Filed With SEC on March 18, 2013)
- ASSET PURCHASE AGREEMENT between BRISTOL-MYERS SQUIBB COMPANY, and SYNERGY PHARMACEUTICALS, INC. Dated as of August 17, 2012 (Filed With SEC on October 25, 2012)
- 10,000,000 Shares of Common Stock SYNERGY PHARMACEUTICALS INC. UNDERWRITING AGREEMENT (Filed With SEC on May 4, 2012)
- AMENDED AND RESTATED SYNERGY PHARMACEUTICALS, INC. WARRANT AGENCY AGREEMENT (Filed With SEC on December 16, 2011)
- SYNERGY PHARMACEUTICALS, INC. WARRANT AGENCY AGREEMENT (Filed With SEC on December 1, 2011)
- $15,000,000 of Units SYNERGY PHARMCEUTICALS, INC. Units Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 1, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 15, 2011)
- COMMON STOCK PURCHASE WARRANT SYNERGY PHARMACEUTICALS, INC. (Filed With SEC on November 15, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 14, 2011)
- COMMON STOCK PURCHASE WARRANT SYNERGY PHARMACEUTICALS, INC. (Filed With SEC on October 14, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 6, 2011)
- COMMON STOCK PURCHASE WARRANT SYNERGY PHARMACEUTICALS, INC. (Filed With SEC on October 6, 2011)
- SYNERGY PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENT SECTION 1. (Filed With SEC on August 3, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 6, 2011)
- COMMON STOCK PURCHASE WARRANT SYNERGY PHARMACEUTICALS, INC. (Filed With SEC on May 6, 2011)
- LOAN AGREEMENT (Filed With SEC on March 16, 2011)
- SYNERGY PHARMACEUTICALS, INC. 17% Note Due: April 1, 2011 (Filed With SEC on March 16, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 10, 2011)
- COMMON STOCK PURCHASE WARRANT SYNERGY PHARMACEUTICALS, INC. Warrant Shares: Initial Exercise Date: (Filed With SEC on March 10, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 5, 2010)
